| abstract |
The present invention includes a composition comprising a plurality of microcapsules, a microcapsule of the plurality comprising at least one cannabinoid compound, and methods comprising administering to a subject in need thereof a therapeutically effective amount of the composition, wherein the administering effects, in the subject, one or more members selected from the group consisting of (i) reduced expression or activity of a cytokine in a target cell, when the administering occurs to the subject having a viral infection, (ii) reduced platelet activation, and (iii) reduced expression or activity of angiotensin pathway protein in a target cell, as compared to a corresponding control. |